IL-34 expression is reduced in hashimoto's thyroiditis and associated with thyrocyte apoptosis

23Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

Hashimoto's thyroiditis (HT) is a common autoimmune disease accompanied by lymphocyte infiltration and thyroid tissue destruction. IL-34 was first described in 2008, and its involvement in the development of many autoimmune diseases has been recently identified. However, whether IL-34 is a regulatory factor in HT is unclear. Here, we demonstrate that IL-34 is expressed on thyroid follicular epithelial cells and that IL-34 expression is significantly reduced in thyroid tissue in patients with HT and spontaneous autoimmune thyroiditis (SAT) models. Serum IL-34 levels in patients with HT are also significantly reduced. In addition, IL-34 is associated with thyroid autoantibodies in both thyroid tissue and serum. Furthermore, our data show that IL-34 participates in the apoptosis resistance of thyrocytes in HT induced by CSF-1R and may be a potential indicator for evaluating thyrocyte damage.

Cite

CITATION STYLE

APA

Wang, S., Liu, Y., Zhao, N., Cui, X., Huang, M., Li, Y., … Teng, W. (2018). IL-34 expression is reduced in hashimoto’s thyroiditis and associated with thyrocyte apoptosis. Frontiers in Endocrinology, 9(OCT). https://doi.org/10.3389/fendo.2018.00629

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free